Skip to main content
Log in

Veratrum Poisoning

  • Review Article
  • Published:
Toxicological Reviews

Abstract

Several species of the Veratrum genus are associated with toxicity in humans and animals. The principal toxins are steroid alkaloids; some have a modified steroid template, whereas others differ in their esterified acid moieties. These alkaloids act by increasing the permeability of the sodium channels of nerve cells, causing them to fire continuously. Increased stimulation, associated with the vagal nerve results in a reflex that causes the triad of responses known as the Bezold-Jarisch reflex: hypotension, bradycardia and apnoea. Clinically, various Veratrum extracts were marketed for clinical use as antihypertensive drugs, but because of their narrow therapeutic index were withdrawn from the market. Following the ingestion of Veratrum alkaloids, expected signs and symptoms include vomiting and abdominal pain, followed by cardiovascular effects such as bradycardia, hypotension and cardiac conduction abnormalities and death. Similar symptoms arise in other mammalian species ingesting these alkaloids; teratogenic effects may occur to the fetuses of animals that have grazed on Veratrum californicum. Treatment consists of supportive care, with an emphasis on haemodynamic stability with fluid replacement, atropine and vasopressors. The onset of symptoms occurs between 30 minutes and 4 hours, and the duration of the illness can range from 1 to 10 days; however, with prompt supportive care, patients typically make a full recovery within 24 hours.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Notes

  1. The use of trade names is for product identification purposes only and does not imply endorsement.

References

  1. Zomlefer WB, Whitten WM, Williams NH, et al. An overview of Veratrum s.1. (Liliales: Melanthiaceae) and an infrageneric phytogeny based on ITS sequence data. Syst Bot 2003; 28(2): 250–69

    Google Scholar 

  2. Kupchan SM, Zimmerman JH, Afonso A. The alkaliods and taxonomy of Veratrum and related genera. Lloydia 1961; 24(1): 1–26

    Google Scholar 

  3. Meilman E, Krayer O. The effects of protoveratrine, a pure Veratrum alkaloid in hypertensive patients. J Clin Invest 1950; 29(6): 833–4

    PubMed  CAS  Google Scholar 

  4. Krayer O, Meilman E. Veratrum alkaloids with antihypertensive activity. In: Gross F, editor. Antihypertensive agents. New York: Springer-Verlag, 1977: 547–70

    Google Scholar 

  5. Huxley AJ, Griffiths M. The Royal Horticultural Society dictionary of gardening. London: Macmillan Press, 1992

    Google Scholar 

  6. Kingsbury JM. Poisonous plants of the United States and Canada. Englewood Cliffs (NJ): Prentice-Hall, 1964

    Google Scholar 

  7. Nelson DA. Accidental poisoning by Veratrum japonicum: a clinical report. JAMA 1954; 156(1): 33–4

    Article  CAS  Google Scholar 

  8. Morton JF. Major medicinal plants: botany, culture, and uses. Springfield (IL): Thomas, 1977

    Google Scholar 

  9. Grancai D, Grancaiova Z. Veratrum alkaloids. I. Ceska Slov Farm 1994; 43(4): 147–54

    PubMed  CAS  Google Scholar 

  10. Samuelsson G. Drugs of natural origin: a textbook of pharmacognosy. Stockholm: Swedish Pharmaceutical Press, 1992

    Google Scholar 

  11. Gaillard Y, Pepin G. LC-EI-MS determination of veratridine and cevadine in two fatal cases of Veratrum album poisoning. J Anal Toxicol 2001; 25(6): 481–5

    PubMed  CAS  Google Scholar 

  12. McKinney LC, Chakraverty S, Deweer P. Purification, solubility, and pKa of veratridine. Anal Biochem 1986; 153(1): 33–8

    Article  PubMed  CAS  Google Scholar 

  13. Jaspersen-Schib R, Theus L, Guirguis-Oeschger M, et al. Acute poisonings with toxic giants in Switzerland between 1966 and 1994. Schweiz Med Wochenschr 1996; 126(25): 1085–98

    PubMed  CAS  Google Scholar 

  14. Ulbricht W. Effects of veratridine on sodium currents and fluxes. Rev Physiol Biochem Pharmacol 1998; 133: 1–54

    PubMed  CAS  Google Scholar 

  15. Wang SY, Wang GK. Voltage-gated sodium channels as primary targets of diverse lipid-soluble neurotoxins. Cell Signal 2003; 15(2): 151–9

    Article  PubMed  CAS  Google Scholar 

  16. Zucker IH, Cornish KG. The Bezold-Jarisch reflex in the conscious dog. Circ Res 1981; 49(4): 940–8

    Article  PubMed  CAS  Google Scholar 

  17. Nanasi PP, Kiss T, Danko M, et al. Different actions of aconitine and Veratrum alkaloids on frog skeletal-muscle. Gen Pharmacol 1990; 21(6): 863–8

    Article  PubMed  CAS  Google Scholar 

  18. Clozel JP, Pisarri TE, Coleridge HM, et al. Reflex coronary vasodilatation evoked by chemical-stimulation of cardiac afferent vagal c fibers in dogs. Physiol (Lond) 1990; 428: 215–32

    CAS  Google Scholar 

  19. Hainsworth R. Reflexes From the heart. Physiol Rev 1991; 71(3): 617–58

    PubMed  CAS  Google Scholar 

  20. Aviado DM, Guevara Aviado D. The Bezold-Jarisch reflex: a historical perspective of cardiopulmonary reflexes. Ann N Y Acad Sci 2001; 940: 48–58

    Article  PubMed  CAS  Google Scholar 

  21. Jaffe AM, Gephardt D, Courtemanche L. Poisoning due to ingestion of Veratrum viride (false hellebore). J Emerg Med 1990; 8(2): 161–7

    Article  PubMed  CAS  Google Scholar 

  22. Schuetz E. Multi-system toxicity from intentional hellebore ingestion. J Toxicol Clin Toxicol 1998; 36(5): 454

    Google Scholar 

  23. Quatrehomme G, Bertrand F, Chauvet C, et al. Intoxication from Veratrum album. Hum Exp Toxicol 1993; 12(2): 111–5

    Article  PubMed  CAS  Google Scholar 

  24. Prince LA, Stork CM. Prolonged cardiotoxicity from poison lilly (Veratrum viride). Vet Hum Toxicol 2000; 42(5): 282–5

    PubMed  CAS  Google Scholar 

  25. Krayer O, Acheson GH. The pharmacology of the Veratrum alkaloids. Physiol Rev 1946; 26: 383–446

    PubMed  CAS  Google Scholar 

  26. Meilman E. The management of hypertensive cardiovascular disease. Circulation 1956; 13(4): 596–607

    Article  PubMed  CAS  Google Scholar 

  27. Meilman E, Krayer O. Clinical studies on Veratrum alkaloids 1: the action of protoveratrine and veratridine in hypertension. Circulation 1950; 1(2): 204–13

    Article  PubMed  CAS  Google Scholar 

  28. Meilman E, Krayer O. Clinical studies on Veratrum alkaloids 2: the dose-response relations of protoveratrine in hypertension. Circulation 1952; 6(2): 212–21

    Article  PubMed  CAS  Google Scholar 

  29. Currens JH, Myers GS, White PD. The use of protoveratrine in the treatment of hypertensive vascular disease. Am Heart J 1953; 46(4): 576–92

    Article  PubMed  CAS  Google Scholar 

  30. Wilkins RW. Veratrum viride in hypertensive cardiovascular disease. Mod Concepts Cardiovasc Dis 1951; 20(2): 89–90

    PubMed  CAS  Google Scholar 

  31. Kauntze R, Trounce J. The hypotensive action of veriloid (Veratrum viride): a clinical investigation. Lancet 1951; 260: 549–55

    Article  Google Scholar 

  32. Barrow JG, Sikes CR. The use of purified Veratrum viride alkaloids in the treatment of essential hypertension. Am Heart J 1951; 41(5): 742–5

    Article  PubMed  CAS  Google Scholar 

  33. Beasley J, Robinson K. Intolerance to veriloid. BMJ 1954; 4857: 316–7

    Article  Google Scholar 

  34. Gray IR, Hamer NAJ. Protoveratrine A in treatment of hypertension. BMJ 1957 Sep 14; 2: 609–12

    Article  PubMed  CAS  Google Scholar 

  35. Kolb EJ, Korein J. Neuromuscular toxicity of Veratrum alkaloids. Neurobiology 1961; 11(2): 159–63

    Google Scholar 

  36. Kauntze R, Trounce J. Treatment of arterial hypertension with veriloid (Veratrum viride). Lancet 1951; 261: 1002–8

    Article  Google Scholar 

  37. Winer BM. Comparative studies of protoveratrine-A and protoveratrine-B intravenously in hypertensive man. Circulation 1960; 22(6): 1074–82

    Article  PubMed  CAS  Google Scholar 

  38. Page LB, Sidd JJ. Medical management of primary hypertension 3. N Engl J Med 1972; 287(21): 1074–80

    Article  PubMed  CAS  Google Scholar 

  39. Connelly JP. Toxic hazards; accidental ingestion of a Veratrum alkaloid. N Engl J Med 1957; 257(12): 577–8

    Article  PubMed  CAS  Google Scholar 

  40. Garnier R, Carlier P, Hoffelt J, et al. Acute dietary poisoning by white hellebore (Veratrum album L.): clinical and analytical data: a propos of 5 cases. Ann Med Interne (Paris) 1985; 136(2): 125–8

    CAS  Google Scholar 

  41. Festa M, Andreetto B, Ballaris MA, et al. A case of Veratrum poisoning. Minerva Anestesiol 1996; 62(5): 195–6

    PubMed  CAS  Google Scholar 

  42. Zagler B, Zelger A, Salvatore C, et al. Dietary poisoning with Veratrum album: a report of two cases. Wien Klin Wochenschr 2005; 117(3): 106–8

    Article  PubMed  Google Scholar 

  43. Underhill JE. Case of hellebore poisoning. Can Field Nat 1958; 73: 128–9

    Google Scholar 

  44. Crummett D, Bronstein D, Weaver Z. Accidental Veratrum viride poisoning in three ‘ramp’ foragers. North Carolina Med J 1985; 46(9): 469–71

    CAS  Google Scholar 

  45. Seeliger J. Unusual case of poisoning with white hellebore. Arch Toxikol 1956; 16(1): 16–8

    Article  PubMed  CAS  Google Scholar 

  46. Komchatov IN, Nasirov GS. Poisoning by a tincture of false hellebore. Sud Med Ekspert 1988; 31(1): 51–2

    PubMed  Google Scholar 

  47. Berezhnitskii MN, Parashchak AP. 2 cases of poisoning with Veratrum album tincture. Sov Med 1969; 32(2): 141

    PubMed  CAS  Google Scholar 

  48. Fogh A, Kulling P, Wickstrom E. Veratrum alkaloids in sneezing-powder: a potential danger. J Toxicol Clin Toxicol 1983; 20(2): 175–9

    Article  PubMed  CAS  Google Scholar 

  49. Carlier P, Efthymiou ML, Garnier R, et al. Poisoning with Veratrum-containing sneezing powders. Hum Toxicol 1983; 2(2): 321–5

    Article  PubMed  CAS  Google Scholar 

  50. Carlier P, Garnier R, Efthymiou ML. An instance of toxivigilance: poisonings with a Veratrum album-containing sneezing powder. J Toxicol Med 1983; 3(2): 113–7

    Google Scholar 

  51. Grant WM, Schuman JS. Toxicology of the eye. Springfield (IL): Charles C. Thomas, 1993

    Google Scholar 

  52. Swiss ED, Bauer RO. Acute toxicity of Veratrum derivatives. Proc Soc Exp Biol Med 1951; 76(4): 847–9

    PubMed  CAS  Google Scholar 

  53. Garner RJ. Garner’s veterinary toxicology. 3rd ed. Baltimore (MD): Williams and Wilkins, 1967

    Google Scholar 

  54. Mulligan GA, Munro DB. The biology of Canadian weeds 77. Veratrum viride Ait. Can J Plant Sci 1987; 67(3): 777–86

    Article  Google Scholar 

  55. Binns W, James LF, Shupe JL, et al. A congenital cyclopian-type malformation in lambs induced by maternal ingestion of a range plant, Veratrum californicum. Am J Vet Res 1963; 24: 1164–75

    PubMed  CAS  Google Scholar 

  56. Babbott FL, Ingalls TH, Utah L, et al. Field studies of cyclopian malformations in sheep. Arch Environ Health 1962; 5(2): 109–13

    PubMed  Google Scholar 

  57. Allen SD. A cyclopian fetus resulting from oral ingestion of Veratrum californicum. Iowa State Univ Vet 1970; 2: 62–5

    Google Scholar 

  58. Binns W, Keeler RF, Balls LD. Congenital deformities in lambs, calves, and goats resulting from maternal ingestion of Veratrum californicum: hare lip, cleft-palate, ataxia, and hypoplasia of metacarpal and metatarsal bones. Clin Toxicol 1972; 5(2): 245–61

    Article  PubMed  CAS  Google Scholar 

  59. Keeler RF, Binns W. Teratogenic compounds of Veratrum californicum (Durand) II: production of ovine fetal cyclopia by fractions and alkaloid preparations. Can J Biochem 1966; 44(6): 829–38

    Article  PubMed  CAS  Google Scholar 

  60. Keeler RF, Binns W. Teratogenic compounds of Veratrum californicum (Durand) V: comparison of cyclopian effects of steroidal alkaloids From plant and structurally related compounds from other sources. Teratology 1968; 1(1): 5–10

    Article  PubMed  CAS  Google Scholar 

  61. Campbell MA, Brown KS, Hassell JR, et al. Inhibition of limb chondrogenesis by a Veratrum alkaloid: temporal specificity in vivo and in vitro. Dev Biol 1985; 111(2): 464–70

    Article  PubMed  CAS  Google Scholar 

  62. Browne CA, Sim FR, Rae ID, et al. Isolation of teratogenic alkaloids by reversed-phase high-performance liquid chromatography. J Chromatogr 1984; 336(1): 211–20

    Article  PubMed  CAS  Google Scholar 

  63. Magnani B, Woolf AD. Cardiotoxic plants. In: Brent J, Wallace KL, Burkhart KK, et al., editors. Critical care toxicology: diagnosis and management of the critically poisoned patient. Philadelphia (PA): Elsevier Mosby, 2005: 1325–34

    Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this review. The author has no conflicts of interest that are directly relevant to the content of this review. The author wishes to acknowledge Jill Turner from the Centre for Economic Botany at the Royal Botanic Gardens, Kew, for her assistance in sourcing lesser known research articles for this review.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leo J. Schep.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schep, L.J., Schmierer, D.M. & Fountain, J.S. Veratrum Poisoning. Toxicol Rev 25, 73–78 (2006). https://doi.org/10.2165/00139709-200625020-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00139709-200625020-00001

Keywords

Navigation